SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-24-007686
Filing Date
2024-01-29
Accepted
2024-01-29 16:00:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm244117d16_sc13g.htm SC 13G/A 43193
  Complete submission text file 0001104659-24-007686.txt   44772
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89486 | Film No.: 24573546
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address 200 CENTRAL AVENUE ST. PETERSBURG FL 33701
Business Address 200 CENTRAL AVENUE ST. PETERSBURG FL 33701 212-426-7040
ARK Investment Management LLC (Filed by) CIK: 0001697748 (see all company filings)

IRS No.: 464309299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A